Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours.

Oncogene - 19 Jul 2001

Sibley K, Stern P, Knowles M A

Abstract excerpt

Mutations in FGFR3 have been identified in several tumour types including bladder carcinoma, cervical carcinoma, and multiple myeloma. In bladder carcinoma, we recently identified FGFR3 mutations in 41% of tumours, making this the most frequently mutated putative oncogene identified in bladder cancer to date. We have now investigated the frequency of FGFR3 mutation in a panel of 125 tumours and 13 cell lines from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to DNA, Neoplasm
Share to Protein-Tyrosine Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Receptor, Fibroblast Growth Factor, Type 3

Share to Receptors, Fibroblast Growth Factor

Share to Tumor Cells, Cultured

Share to Urinary Bladder Neoplasms

Share to Uterine Cervical Neoplasms

Source

Identifiers

PMID: 11466624
DOI: 10.1038/sj.onc.1204543

Genes

FGFR3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours.PMID 11466624Read ↗

Incidence of fibroblast growth factor receptor 3 gene (FGFR3) A248C, S249C, G372C, and T375C mutations in bladder cancer.Semantic proximity Read ↗

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.Semantic proximity Read ↗

Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3bSemantic proximity Read ↗

Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target.Semantic proximity Read ↗

The role of mutations and overexpression of the fibroblast growth factor receptor-3 in bladder cancer.Semantic proximity Read ↗

FGFR3 – a Central Player in Bladder Cancer Pathogenesis?Semantic proximity Read ↗

FGFR3 mutational status and protein expression in patients with bladder cancer in a Jordanian population.Semantic proximity Read ↗

Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer.Semantic proximity Read ↗

Frequent FGFR3 mutations in urothelial papillomaSemantic proximity Read ↗

Frequency of activating mutations in FGFR2 exon 7 in bladder tumors from patients with early-onset and regular-onset disease.Semantic proximity Read ↗

Fibroblast growth factor receptor (FGFR) gene: pathogenesis and treatment implications in urothelial carcinoma of the bladder.Semantic proximity Read ↗

Clinical and biological characteristics of cervical neoplasias with FGFR3 mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.